TY - JOUR
T1 - Low rate of invasive coronary angiography following transcatheter aortic valve implantation
T2 - real-world prospective cohort findings
AU - Gonçalves, Mariana
AU - Gonçalves, Pedro de Araújo
AU - Campante Teles, Rui
AU - de Sousa Almeida, Manuel
AU - Félix de Oliveira, Afonso
AU - Brito, João
AU - Raposo, Luís
AU - Mesquita Gabriel, Henrique
AU - Nolasco, Tiago
AU - Neves, José Pedro
AU - Mendes, Miguel
AU - Garcia-Garcia, Hector M.
N1 - Funding Information:
The authors would like to thank Dr. Catarina Brízido1 MD, Dr. Gustavo de Sá Mendes1 MD, Dr. Gonçalo Cunha1 MD, Dr. Pedro Lopes1 MD, Dr. Bruno Rocha1 MD, Dr. João Presume1 MD, Dr. Sérgio Maltês1 MD, Dr. Francisco Albuquerque1 MD and Dr. Francisco Gama1 MD who were responsible for data collection.
Publisher Copyright:
© 2020
PY - 2021/7
Y1 - 2021/7
N2 - Aim: To evaluate the real need for coronary access after transcatheter aortic valve implantation (TAVI). Methods and results: Prospective observational single-center registry, including 563 consecutive patients who underwent TAVI between April 2008 and November 2018, with both self- and balloon-expandable valves in a tertiary European center. Mean age was 82.4 ± 6.9 years, 53.3% were female, 16% had previous history of coronary artery bypass grafting, 33% of previous percutaneous coronary intervention (PCI), and 16.6% of myocardial infarction (MI). Twenty-four percent of the patients were revascularized within one year before TAVI in preparation for the procedure. Median Society of Thoracic Surgeons score was 4.82 (IQ 2.84). In a median follow-up of 24 months (IQ 21.5), 18 patients (3.2%) were identified as potentially in need for invasive coronary angiography: 9 (1.6%) in the setting of stable coronary artery disease and 9 (1.6%) for an acute coronary syndrome. A total of 11 PCIs were performed in 9 patients, with a complete success rate of 63.6%. Procedures that were unsuccessful or partially unsuccessful were due to the inability to cross the stent or the drug-eluting balloon through the valve struts or misplacement within the coronary artery due to lack of catheter support. Conclusion: In this population, a strategy of previous guideline-directed revascularization before TAVI was associated with a low rate of MI and repeated need of coronary access, with a scattered distribution over time. Assuring future access to coronary arteries in patients at increased risk may depend on the revascularization strategy rather than device selection.
AB - Aim: To evaluate the real need for coronary access after transcatheter aortic valve implantation (TAVI). Methods and results: Prospective observational single-center registry, including 563 consecutive patients who underwent TAVI between April 2008 and November 2018, with both self- and balloon-expandable valves in a tertiary European center. Mean age was 82.4 ± 6.9 years, 53.3% were female, 16% had previous history of coronary artery bypass grafting, 33% of previous percutaneous coronary intervention (PCI), and 16.6% of myocardial infarction (MI). Twenty-four percent of the patients were revascularized within one year before TAVI in preparation for the procedure. Median Society of Thoracic Surgeons score was 4.82 (IQ 2.84). In a median follow-up of 24 months (IQ 21.5), 18 patients (3.2%) were identified as potentially in need for invasive coronary angiography: 9 (1.6%) in the setting of stable coronary artery disease and 9 (1.6%) for an acute coronary syndrome. A total of 11 PCIs were performed in 9 patients, with a complete success rate of 63.6%. Procedures that were unsuccessful or partially unsuccessful were due to the inability to cross the stent or the drug-eluting balloon through the valve struts or misplacement within the coronary artery due to lack of catheter support. Conclusion: In this population, a strategy of previous guideline-directed revascularization before TAVI was associated with a low rate of MI and repeated need of coronary access, with a scattered distribution over time. Assuring future access to coronary arteries in patients at increased risk may depend on the revascularization strategy rather than device selection.
KW - Aortic stenosis
KW - Catheter engagement
KW - Coronary artery disease
KW - Invasive coronary angiography
KW - Transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85090560365&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2020.07.030
DO - 10.1016/j.carrev.2020.07.030
M3 - Article
C2 - 32921596
AN - SCOPUS:85090560365
SN - 1553-8389
VL - 28
SP - 42
EP - 49
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -